Clinical Topics
-
Is early-onset cancer an emerging global epidemic? -
Cost paramount when choosing metastatic breast cancer treatment -
Genetic tests create treatment opportunities and confusion for breast cancer patients -
Time to cancer diagnoses in U.S. averages 5 months -
Single Institution Retrospective Review of Patterns of Care and Disease Presentation in Female Veterans With Breast Cancer During the COVID-19 Pandemic
Digital Edition
Multimedia
Conference Coverage
-
ER+/HER2– breast cancer: Is first or second line CDK4/6 inhibitor therapy better? -
Ribociclib forestalls recurrence also in early breast cancer -
Phone support helps weight loss in patients with breast cancer -
Chemo avoidance pays off for some women with HER2+ early BC -
BC: Meta-analysis supports ovarian suppression/ablation -
Circulating tumor DNA may predict poor prognosis in breast cancer -
Breast cancer outcomes are worse for Black men -
Breast cancer survivors need a comprehensive care plan, says doctor -
PARP inhibitors and breast cancer: Questions remain about wider use -
Genomic assay changes minds on HER2+ BC treatment
Question 1 of 5
